Search research articles
Contact Us
Filters
Showing results (1-10 of 146) with videos related to
Page
of 15
Sort By:
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Prolactin and breast cancer
M L'Hermite, M L'Hermite-Baleriaux
Climacteric : the Journal of the International Menopause Society
|
March 17, 2017
Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal
M L'Hermite
Maturitas
|
September 1, 1990
Risks of estrogens and progestogens
M L'Hermite
Acta Cardiologica
|
January 1, 1991
Sex hormones and cardiovascular risk
M L'Hermite
Clinics in Endocrinology and Metabolism
|
November 1, 1973
The present status of prolactin assays in clinical practice
M L'Hermite
Climacteric : the Journal of the International Menopause Society
|
May 17, 2017
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
M L'Hermite
Climacteric : the Journal of the International Menopause Society
|
July 16, 2013
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
M L'Hermite
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
October 15, 1980
[Clinical study of veralipride in menopausal sudden flushes (author's transl)]
S Wesel, M L'Hermite
Annales D'Endocrinologie
|
July 1, 1972
[Human pituitary prolactin: radioimmunologic detection and level during pregnancy]
M L'Hermite, C Robyn
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
October 27, 2009
[Asphyxiating thoracic dysplasia (Jeune syndrome): about two cases]
K Harou, M L'Hermite
Page
of 15
Search research articles
Search
Showing results (1-10 of 146) with videos related to
Sort By:
Page
of 15
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Prolactin and breast cancer
M L'Hermite, M L'Hermite-Baleriaux
Climacteric : the Journal of the International Menopause Society
|
March 17, 2017
Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal
M L'Hermite
Maturitas
|
September 1, 1990
Risks of estrogens and progestogens
M L'Hermite
Acta Cardiologica
|
January 1, 1991
Sex hormones and cardiovascular risk
M L'Hermite
Clinics in Endocrinology and Metabolism
|
November 1, 1973
The present status of prolactin assays in clinical practice
M L'Hermite
Climacteric : the Journal of the International Menopause Society
|
May 17, 2017
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
M L'Hermite
Climacteric : the Journal of the International Menopause Society
|
July 16, 2013
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
M L'Hermite
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
October 15, 1980
[Clinical study of veralipride in menopausal sudden flushes (author's transl)]
S Wesel, M L'Hermite
Annales D'Endocrinologie
|
July 1, 1972
[Human pituitary prolactin: radioimmunologic detection and level during pregnancy]
M L'Hermite, C Robyn
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
October 27, 2009
[Asphyxiating thoracic dysplasia (Jeune syndrome): about two cases]
K Harou, M L'Hermite
Page
of 15